Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beryl Drugs Ltd has submitted compliance certificates to BSE for the quarter ended March 31, 2025. The filing includes a Regulation 74(5) certificate under SEBI (Depositories and Participants) Regulations, 2018 and a Regulation 7(3) certificate confirming that both physical and electronic share transfer facilities were maintained throughout the financial year 2024-25. The company's Registrar and Share Transfer Agent, Adroit Corporate Services Private Limited (SEBI Registration No. INR000002227), has certified the maintenance of these transfer activities. The certificates are signed by Managing Director Sanjay Sethi and a representative of Adroit Corporate Services.
This is a routine regulatory compliance filing with no material impact on shareholders or stock price. It simply confirms the company is meeting its basic listing obligations regarding share transfer facilities.